Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Rapidly Dissolving Olanzapine for Acute Primary Headache
NCT03066622Phase 4Completed
- Sponsor
- HealthPartners Institute
- Start
- Jul 2016
- Primary completion
- May 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of olanzapine, sponsored by HealthPartners Institute. Started Jul 2016; status: completed.
02
Drugs
olanzapine
Beyond the preview
Go deeper on NCT03066622.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03066622.